72364-91-1

Usage

InChI:InChI=1/C12H9N3O2/c1-5-3-7-8(4-6(5)2)12(17)10-9(11(7)16)13-15-14-10/h3-4H,1-2H3,(H,13,14,15)

Upstream product

• 72365-03-8 N-(3-Amino-1,4-dihydroxy-6,7-dimethyl-naphthalen-2-yl)-acetamide 
• 79707-03-2 4,9-dihydro-6,7-dimethyl-4,9-dioxo-1-(4-methoxybenzyl)naphtho<2,3-d>-v-triazole 
• 72364-90-0 2-acetamido-3-bromo-6,7-dimethyl-1,4-naphthoquinone 
• 41791-77-9 2,3-dibromo-6,7-dimethyl-1,4-naphthoquinone 
• 6944-78-1 2-amino-3-bromo-6,7-dimethyl-1,4-naphthoquinone 
• 18691-24-2 2-acetamido-3-amino-6,7-dimethyl-1,4-naphthoquinone 
• 2202-79-1 6,7-dimethyl-1,4-naphthoquinone 

Relevant academic research and scientific papers

Studies on v-triazoles. 9. Antiallergic 4,9-dihydro-4,9-dioxo-1H-naphtho[2,3-d]-v-triazoles

A short series of the title compounds was prepared and evaluated for antiallergic activity in the rat passive cutaneous anaphylaxis screen. All but the two N-methylated derivatives were active in this screen by the intravenous route, the most potent being

Polycyclic triazoles used to inhibit allergic responses

Compounds of formula (I): STR1 and pharmaceutically acceptable salts thereof wherein R1, R2, R3 and R4 which may be the same or different, represent hydrogen, halogen, nitro, lower alkyl, or lower alkoxy, or any adjacent two of R1 to R4 taken together represent an alkylene group containing from 3 to 5 carbon atoms or a 1,4-buta-1,3-dienylene group are disclosed together with a method for their preparation. The compounds are useful as anti-allergic agents. With the exception of 4,9-dioxo-1H-naphtho-[2,3-d]-triazole, and its salts, all compounds of formula (I) are novel.